Publications by authors named "Weipeng Yong"

Claim this Profile
F
Final Results from a First-in-Human Phase I Study of the Dual Isocitrate Dehydrogenase (IDH) 1/2 Inhibitor, LY3410738, in Advanced Solid Tumors Harboring IDH1 or IDH2 Mutations.
James J Harding, Do-Youn Oh, Teresa Macarulla Mercade, Lipika Goyal, Andreas Varkaris, Wei-Peng Yong

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asia Pacific Gastroesophageal Cancer Congress (APGCC) 2024 consensus statement on stage 2 and 3 locally advanced gastric and Siewert 3 junctional adenocarcinoma.
Yoshio Masuda, Kang Ler Fong, Danson Yeo, Charleen Yeo, Koy Min Chue, Wei-Peng Yong

J Gastroenterol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asian consensus on normothermic intraperitoneal and systemic treatment for gastric cancer with peritoneal metastasis.
Zhenggang Zhu, Joji Kitayama, Hyung-Ho Kim, Jimmy Bok-Yan So, Hui Cao, Wei-Peng Yong

Gastric Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Click Covalent-Targeted Radionuclide Therapy for Prostate Cancer.
Weipeng Yong, Shu Zhang, Zhoudong Zhang, Zhihao Li, Yu Qin, Zhiyong Liu

J Med Chem· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies.
Cheng E Chee, Melissa Ooi, Soo-Chin Lee, Raghav Sundar, Valerie Heong, Wei-Peng Yong

Target Oncol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome and prognostic factors for Asian patients in Phase I clinical trials.
Jerold Loh, Jiaxuan Wu, Jenny Chieng, Aurora Chan, Wei-Peng Yong

Br J Cancer· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FAM3C in circulating tumor-derived extracellular vesicles promotes non-small cell lung cancer growth in secondary sites.
Win Lwin Thuya, Li Ren Kong, Nicholas L Syn, Ling-Wen Ding, Esther Sok Hwee Cheow, Wei-Peng Yong

Theranostics· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Polydopamine-Coated Radiolabeled Microspheres for Combinatorial Radioembolization and Photothermal Cancer Therapy.
Manran Wu, Lei Zhang, Kexin Shi, Dongxu Zhao, Weipeng Yong

ACS Appl Mater Interfaces· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical translation of patient-derived tumour organoids- bottlenecks and strategies.
Malia Alexandra Foo, Mingliang You, Shing Leng Chan, Gautam Sethi, Glenn K Bonney, Wei-Peng Yong

Biomark Res· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redox-sensitive iodinated polymersomes carrying histone deacetylase inhibitor as a dual-functional nano-radiosensitizer for enhanced radiotherapy of breast cancer.
Zhehong Zhu, Manran Wu, Juan Sun, Zhengyuan Huangfu, Lingling Yin, Weipeng Yong

Drug Deliv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
Robin Kate Kelley, Bruno Sangro, William Harris, Masafumi Ikeda, Takuji Okusaka, Wei-Peng Yong

J Clin Oncol· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer-T cell coculture models.
Kosaku Mimura, Ley-Fang Kua, Jin-Fen Xiao, Bernadette Reyna Asuncion, Yuko Nakayama, Wei-Peng Yong

Gastric Cancer· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune suppression caused by PD-L2 expression on tumor cells in gastric cancer.
Yuko Nakayama, Kosaku Mimura, Ley-Fang Kua, Hirokazu Okayama, Aung Kyi Thar Min, Wei-Peng Yong

Gastric Cancer· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A unique CDK4/6 inhibitor: Current and future therapeutic strategies of abemaciclib.
Qing-Yun Chong, Ze-Hui Kok, Ngoc-Linh-Chi Bui, Xiaoqiang Xiang, Andrea Li-Ann Wong, Wei-Peng Yong

Pharmacol Res· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resisting resistance to cancer immunotherapy.
Walter Sze-Tung Lam, Louis Zizhao Wang, Raheleh Roudi, Wei-Peng Yong, Nicholas L Syn

Thorac Cancer· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 expression is mainly regulated by interferon gamma associated with JAK-STAT pathway in gastric cancer.
Kousaku Mimura, Jun Liang Teh, Hirokazu Okayama, Kensuke Shiraishi, Ley-Fang Kua, Wei-Peng Yong

Cancer Sci· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of thioredoxin-1 in activated human NK cells confers increased tolerance to oxidative stress.
Kousaku Mimura, Ley-Fang Kua, Noriko Shimasaki, Kensuke Shiraishi, Shotaro Nakajima, Wei-Peng Yong

Cancer Immunol Immunother· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intraperitoneal chemotherapy for gastric cancer with peritoneal disease: experience from Singapore and Japan.
Koji Kono, Wei-Peng Yong, Hirokazu Okayama, Asim Shabbir, Tomoyuki Momma

Gastric Cancer· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of MMP activity can restore NKG2D ligand expression in gastric cancer, leading to improved NK cell susceptibility.
Kensuke Shiraishi, Kousaku Mimura, Ley-Fang Kua, Vivien Koh, Lim Kee Siang, Wei-Peng Yong

J Gastroenterol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accumulation of CD11c+CD163+ Adipose Tissue Macrophages through Upregulation of Intracellular 11β-HSD1 in Human Obesity.
Shotaro Nakajima, Vivien Koh, Ley-Fang Kua, Jimmy So, Lomanto Davide, Wei-Peng Yong

J Immunol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel combinatorial strategy using Seliciclib(®) and Belinostat(®) for eradication of non-small cell lung cancer via apoptosis induction and BID activation.
Pei-Shi Ong, Lingzhi Wang, Deborah Miao-Hui Chia, Jolyn Yu-Xin Seah, Li-Ren Kong, Wei-Peng Yong

Cancer Lett· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine pharmacogenetics: historical milestones and progress toward clinical implementation.
Nicholas Syn, Soo-Chin Lee, Boon-Cher Goh, Wei-Peng Yong

Pharmacogenomics· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
Nicholas Li-Xun Syn, Wei-Peng Yong, Boon-Cher Goh, Soo-Chin Lee

Expert Opin Drug Metab Toxicol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotyping of UGT1A1 Activity Using Raltegravir Predicts Pharmacokinetics and Toxicity of Irinotecan in FOLFIRI.
Lawrence Soon-U Lee, Kok-Yong Seng, Ling-Zhi Wang, Wei-Peng Yong, Kim-Hor Hee

PLoS One· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacogenetics-Guided Phase I Study of Capecitabine on an Intermittent Schedule in Patients with Advanced or Metastatic Solid Tumours.
Ross Andrew Soo, Nicholas Syn, Soo-Chin Lee, Lingzhi Wang, Xn-Yii Lim, Wei-Peng Yong

Sci Rep· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis